DK1349855T3 - 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt - Google Patents

5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt

Info

Publication number
DK1349855T3
DK1349855T3 DK01272109T DK01272109T DK1349855T3 DK 1349855 T3 DK1349855 T3 DK 1349855T3 DK 01272109 T DK01272109 T DK 01272109T DK 01272109 T DK01272109 T DK 01272109T DK 1349855 T3 DK1349855 T3 DK 1349855T3
Authority
DK
Denmark
Prior art keywords
pyridyl
ethoxy
benzyl
amino
methyl
Prior art date
Application number
DK01272109T
Other languages
Danish (da)
English (en)
Inventor
Deirdre O'keeffe
Andrew Simon Craig
Tim Chien Ting Ho
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0031528A external-priority patent/GB0031528D0/en
Priority claimed from GB0031521A external-priority patent/GB0031521D0/en
Priority claimed from GB0031524A external-priority patent/GB0031524D0/en
Priority claimed from GB0031526A external-priority patent/GB0031526D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1349855T3 publication Critical patent/DK1349855T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK01272109T 2000-12-22 2001-12-21 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt DK1349855T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0031528A GB0031528D0 (en) 2000-12-22 2000-12-22 Novel pharmaceutical
GB0031521A GB0031521D0 (en) 2000-12-22 2000-12-22 Novel pharmaceutical
GB0031524A GB0031524D0 (en) 2000-12-22 2000-12-22 Novel pharmaceutical
GB0031526A GB0031526D0 (en) 2000-12-22 2000-12-22 Novel pharmaceuticals

Publications (1)

Publication Number Publication Date
DK1349855T3 true DK1349855T3 (da) 2006-12-27

Family

ID=27447913

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01272109T DK1349855T3 (da) 2000-12-22 2001-12-21 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt

Country Status (12)

Country Link
US (2) US20040082620A1 (de)
EP (1) EP1349855B1 (de)
JP (1) JP2004520326A (de)
KR (1) KR100840846B1 (de)
CN (1) CN1310912C (de)
AT (1) ATE337313T1 (de)
CY (1) CY1106226T1 (de)
DE (1) DE60122580T2 (de)
DK (1) DK1349855T3 (de)
ES (1) ES2270955T3 (de)
PT (1) PT1349855E (de)
WO (1) WO2002051839A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
AU2002343050A1 (en) * 2001-11-21 2003-06-10 Smithkline Beecham P.L.C. 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient
ES2733764T3 (es) * 2003-12-16 2019-12-02 Nektar Therapeutics Método para la preparación de oligo etilenglicol monodisperso
US20060182692A1 (en) * 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
EP2062880A1 (de) 2007-11-22 2009-05-27 Bayer Schering Pharma Aktiengesellschaft 5-[(3,3,3-Trifluor-2-hydroxy-1-arylpropyl)amino]-1H-chinolin-2-one, Verfahren zu ihrer Herstellung und ihre Verwendung als entzündungshemmende Wirkstoffe
DK2621496T4 (en) 2010-09-30 2019-03-18 Astrazeneca Ab Crystalline NALOXOL-PEG CONJUGATE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
DE60122580D1 (de) 2006-10-05
PT1349855E (pt) 2006-12-29
CN1491224A (zh) 2004-04-21
JP2004520326A (ja) 2004-07-08
US7291740B2 (en) 2007-11-06
US20040082620A1 (en) 2004-04-29
WO2002051839A1 (en) 2002-07-04
EP1349855A1 (de) 2003-10-08
CY1106226T1 (el) 2011-06-08
EP1349855B1 (de) 2006-08-23
US20060040993A1 (en) 2006-02-23
ATE337313T1 (de) 2006-09-15
CN1310912C (zh) 2007-04-18
KR20030064855A (ko) 2003-08-02
ES2270955T3 (es) 2007-04-16
KR100840846B1 (ko) 2008-06-23
DE60122580T2 (de) 2007-08-30

Similar Documents

Publication Publication Date Title
DE60112729D1 (de) Hcl-salze von 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dion
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
DE60212434D1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
DE60124119D1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
NO20075507L (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt
SI1265893T1 (sl) Hidrokloridne soli 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-diona